An Act relative to the care and treatment of patients with mitochondrial disease
This Massachusetts bill mandates that state employee health plans and all private health insurance policies issued within the state cover treatments for mitochondrial disease. Specifically, it requires coverage for vitamin and nutritional supplements, including CoEnzyme Q10, various B vitamins, Vitamin C, Vitamin E, Vitamin K1, and L-Carnitine. The law applies to a wide range of insurance types, including those for government workers, private group plans, individual policies, and health maintenance organizations. By amending multiple existing chapters of state law, the bill ensures that anyone with this condition has access to these specific treatments regardless of their insurance source.
Bill status
passed
3 of 4 stages cleared
Introduction
Feb 2023
Committee Review
Mar 2024
House Passage
Feb 2023
Governor
Introduced Feb 16, 2023
Last action May 9, 2024
Floor votes
How they voted
This bill passed the House. No roll call record of that vote is available.
Full legislative history
Actions timeline
Total actions
5
Key actions
1
Committee
2
Mar 11, 2024
Senate · Reported by committee
Bill reported favorably by committee and referred to the committee on Health Care Financing
Feb 16, 2023
House · Passed
House concurred
Feb 16, 2023
Senate · Referred to committee
Referred to the committee on Financial Services
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
John Keenan
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about S 660
Scope: MA
Hi! I can help you understand S 660. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline